Drug Profile
Research programme: anaemia therapeutics - PTC Therapeutics
Latest Information Update: 27 Jul 2010
Price :
$50
*
At a glance
- Originator PTC Therapeutics
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Anaemia
Most Recent Events
- 28 Aug 2007 Early research is ongoing
- 10 May 2006 Early research in Anaemia in USA (unspecified route)